Colgate (CL) CEO Noel R. Wallace Receives RSU & Option Awards
$CL · COLGATE PALMOLIVE COResearch Summary
AI-generated summary of this SEC filing
Colgate (CL) CEO Noel R. Wallace Receives RSU & Option Awards
What Happened
Noel R. Wallace, Chairman, President & CEO of Colgate-Palmolive Co. (CL), was granted two equity awards on September 16, 2026: 29,649 restricted stock units (RSUs) and a stock option award covering 205,197 shares. Both awards were reported as acquired at $0.00 on the Form 4 (awards are compensation grants, not open-market purchases or sales).
Key Details
- Transaction date: 2026-09-16; Form 4 filed 2026-09-18 (filed within the typical 2-business-day window).
- RSU award: 29,649 shares, $0 acquisition price; vests in three equal annual installments (one-third each year). (Footnote F1)
- Option award: 205,197-share option granted, $0 acquisition price; option becomes exercisable in equal annual installments over three years starting on the first anniversary of the 9/16/2026 grant. (Footnotes F2, F3)
- Shares owned after transaction: Not specified in the filing.
- Transaction type codes: A = Award/Grant; the larger grant is a derivative (option) award, not an immediate share purchase.
Context
These awards are company compensation rather than market buys or sales, so they do not represent an immediate cash investment or disposition by the insider. The option will only convert to actual shares if and when exercised according to its vesting/exercise schedule; the RSUs convert to shares as they vest. Such grants are common for executive pay and are routinely reported on Form 4.